Last update 02 Nov 2024

Exatecan mesilate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Exatecan, Exatecan mesilate hydrate (JAN), Exatecan mesylate
+ [11]
Target
Mechanism
TOP1 inhibitors(DNA topoisomerase I inhibitors)
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC25H30FN3O9S
InChIKeyFXQZOHBMBQTBMJ-MWPGLPCQSA-N
CAS Registry197720-53-9

External Link

KEGGWikiATCDrug Bank
D01432Exatecan mesilate-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pancreatic CancerPhase 3
US
01 Jul 2001
Pancreatic CancerPhase 3
CA
01 Jul 2001
Pancreatic CancerPhase 3
PR
01 Jul 2001
Desmoplastic Small Round Cell TumorPhase 2
US
01 Jan 2003
Desmoplastic Small Round Cell TumorPhase 2
CA
01 Jan 2003
Ewing SarcomaPhase 2
US
01 Jan 2003
Ewing SarcomaPhase 2
CA
01 Jan 2003
Primitive Neuroectodermal TumorsPhase 2
US
01 Jan 2003
Primitive Neuroectodermal TumorsPhase 2
CA
01 Jan 2003
Esophageal CarcinomaPhase 2
US
01 Apr 2001
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
Colorectal Cancer
GCC positive
-
Anti-GCC ADC with multimeric linker-exatecan payload
ycwfuvcyzi(nvphnhleoc) = cogwyiglfs dbmanzlcwf (uhwsvpkmai )
Positive
05 Apr 2024
Placebo
ycwfuvcyzi(nvphnhleoc) = fkxmlpmxgk dbmanzlcwf (uhwsvpkmai )
Phase 2
39
kczewdwmpp(mcrrfdeiyw) = jnmakqvvwh xdzrgfyxwr (wmelrpnxnb )
Negative
01 Apr 2007
Phase 3
349
acxazukegp(ehvlrvaoee) = jrssmhdifz ubmeqyhjvg (eeidtbakgw )
Negative
15 Jul 2004
acxazukegp(ehvlrvaoee) = kgnnrafcni ubmeqyhjvg (eeidtbakgw )
Phase 2
41
qlvdmtbxmc(wzsuljpzxe) = kjpdgdsszc oystbxmpnt (gazuutuzmb )
-
15 Jul 2004
Phase 3
339
Ensiv
azpfmtxfjs(ofddhopqpx) = ahotizdatx tkcksxnswc (wntyqbyjtz )
-
15 Jul 2004
azpfmtxfjs(ofddhopqpx) = ighubfyrkk tkcksxnswc (wntyqbyjtz )
Phase 2
39
ahpfaosgvq(ubbjtyfblj) = dyqbaqkoqq crzpocvuzy (vzejznzqbi )
Negative
01 Aug 2003
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free